跳至主要内容

Aim at chemical synthesis through Ibuprofen

 Recently, Pfizer's new crown-specific drug Paxlovid and the national miracle drug Ibuprofen are the most popular drugs in the medical circle. Today we will talk about the synthesis and mechanism of action of Ibuprofen, an evergreen drug! Recently, Ibuprofen has been hard to find, and it has become a well-known hard currency.

Ibuprofen

Ibuprofen, molecular formula C13H18O2, chemical name 2-(4-Isobutylphenyl) propanoic acid. Ibuprofen is a commonly used non-steroidal anti-inflammatory drug (NSAID). By inhibiting cyclooxygenase and reducing the synthesis of prostaglandins, it produces analgesic and anti-inflammatory effects; it acts as an antipyretic through the hypothalamic thermoregulatory center effect. Ibuprofen is generally well tolerated and does not cause clinically significant acute liver injury.

Chemical structure of ibuprofen.webp

 Ibuprofen chemical struture

 Indications for Ibuprofen

Oral administration: used to relieve mild to moderate pain, such as arthralgia, neuralgia, muscle pain, migraine, headache, dysmenorrhea, and toothache, and also reduces fever caused by the common cold or influenza.

Injection administration: for antipyretic and analgesic treatment: treatment of mild to moderate pain, adjunct to opioid analgesics for treating moderate to severe pain; antipyretic therapy of fever.

Mechanism of Action of Ibuprofen

Ibuprofen is a diastereoisomeric chiral drug, including R-ibuprofen and S-ibuprofen. Pharmacokinetic studies indicate that most of the pharmacologically active form of the drug is contributed by its S-enantiomer, which inhibits prostaglandin synthesis. A unidirectional enzymatic conversion of the inactive R-enantiomer to the active S-enantiomer was first reported in the early to mid-1970s. Approximately 40-60% of the R-enantiomer is metabolized in the liver to the S-ibuprofen form. Its anti-inflammatory effect is due to the inhibitory activity of S-ibuprofen on cyclooxygenase (COX), which is responsible for the synthesis of prostaglandins and plays an essential role in neuronal death mediated by exacerbated inflammatory responses. Ibuprofen inhibits COX, reduces nitric oxide (NO) production, and activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma).

Mechanism of action of ibuprofen.webp

 Mechanism of action of Ibuprofen [1]

 Chemical Synthesis of Ibuprofen

Ibuprofen was first patented by Boots Pure Chemical Company in 1961 and approved as an over-the-counter drug in 1984. Since its inception, Ibuprofen has been sold under several brands, including Advil® and Motrin®. The synthesis of Ibuprofen starts from isobutyl benzene. The synthesis procedure includes Friedel-Crafts acylation, reduction, chloride substitution, and Grignard reaction. The products of each step were then analyzed by IR and 1 H NMR spectroscopy, and the final product was confirmed by analysis of melting points.

In 1992, BHC Corporation developed a new sustainable synthesis method that cut the synthesis steps in half. The first step uses anhydrous hydrogen fluoride as a catalyst and solvent, which is then recycled for reuse. Furthermore, the natural beauty behind the BHC method is the reduction of unwanted waste and impurities. Only one molecule of water is produced as a by-product, making for a genuinely green synthesis.

Chemical synthesis of ibuprofen.webp

 Chemical Synthesis of Ibuprofen[2]

In 2009, Andrew R. Bogdan et al. from Florida State University synthesized Ibuprofen using a microreactor. Microreactors are safer, more efficient, and more selective chemical transformations in microchannels or narrow-bore tubes. Using isobutyl benzene and propionic acid as starting materials, the total reaction time was about 10 min, and the yield was 68% crude and 51% after recrystallization (purity 99% by GC and NMR analysis).

Ibuprofen continuous synthesis process.webp

 The continuous synthesis process of Ibuprofen [3]

In 2014, Dr. David R. Snead and Professor Timothy F. Jamison of Massachusetts Institute of Technology (MIT) performed a multi-step continuous reaction using isobutyl benzene and propionyl chloride as raw materials. Ibuprofen was assembled from its basic building blocks in three minutes, with an average yield of more than 90% per step from the starting material to the target compound.

Ibuprofen continuous synthesis process (2).webp

 The continuous synthesis process of Ibuprofen [4] 

 References

[1] Ashish Singh, et al. Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics. Inflammopharmacology. 2021 Feb;29(1):5-14. doi: 10.1007/s10787-020-00764-w.

[2] Mark A. Murphy. Early Industrial Roots of Green Chemistry and the history of the BHC Ibuprofen process invention and its Quality connection. Foundations of Chemistry volume 20, pages121–165 (2018).

[3]Andrew R Bogdan, et al.  The continuous-flow synthesis of Ibuprofen. Angew Chem Int Ed Engl. 2009;48(45):8547-50. doi: 10.1002/anie.200903055.

[4] David R Snead , et al. A three-minute synthesis and purification of ibuprofen: pushing the limits of continuous-flow processing. Angew Chem Int Ed Engl. 2015 Jan 12;54(3):983-7. doi:

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati